This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cooke, M. S. Search for Related Content PubMed PubMed Citation Articles by Cooke, M. S. Related Collections Review Epidemiology and Prevention Epidemiology and Prevention: Screening, Behavior, and Survivorship

Measurement and Meaning of Oxidatively Modified DNA Lesions in Urine

¹ Radiation and Oxidative Stress Section, Department of Cancer Studies and Molecular Medicine and ² Department of Genetics, University of Leicester, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom; ³ Department of Clinical Biochemistry, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland; and ⁴ Environmental and Occupational Health, Institute of Public Health, University of Copenhagen, Copenhagen, Denmark

Requests for reprints: Marcus S. Cooke, Radiation and Oxidative Stress Section, Department of Cancer Studies and Molecular Medicine and Department of Genetics, University of Leicester, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, LE2 7LX, United Kingdom. Phone: 44-0-116-252-5825; Fax: 44-0-116-252-5832. E-mail: msc5{at}le.ac.uk

Background: Oxidatively generated damage to DNA has been implicated in the pathogenesis of a wide variety of diseases. The noninvasive assessment of such damage, i.e., in urine, and application to large-scale human studies are vital to understanding this role and devising intervention strategies.

Methods: We have reviewed the literature to establish the status quo with regard to the methods and meaning of measuring DNA oxidation products in urine.

Results: Most of the literature focus upon 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG), and whereas a large number of these reports concern clinical conditions, there remains (a) lack of consensus between methods, (b) possible contribution from diet and/or cell death, (c) no definitive DNA repair source of urinary 2'-deoxyribonucleoside lesions, and (d) no reference ranges for healthy or diseased individuals.

Conclusions: The origin of 8-oxodG is not identified; however, recent cell culture studies suggest that the action of Nudix hydrolase(s) on oxidative modification of the nucleotide pool is a likely candidate for the 8-oxodG found in urine and, potentially, of other oxidized 2'-deoxyribonucleoside lesions. Literature reports suggest that diet and cell death have minimal, if any, influence upon urinary levels of 8-oxodG and 8-oxo-7,8-dihydroguanine, although this should be assessed on a lesion-by-lesion basis. Broadly speaking, there is consensus between chromatographic techniques; however, ELISA approaches continue to overestimate 8-oxodG levels and is not sufficiently specific for accurate quantification. With increasing numbers of lesions being studied, it is vital that these fundamental issues are addressed. We report the formation of the European Standards Committee on Urinary (DNA) Lesion Analysis whose primary goal is to achieve consensus between methods and establish reference ranges in health and disease. (Cancer Epidemiol Biomarkers Prev 2008;17(1):3–14)

This article has been cited by other articles:

				R. G. Sturmey, J. A. Hawkhead, E. A. Barker, and H. J. Leese DNA damage and metabolic activity in the preimplantation embryo Hum. Reprod., January 1, 2009; 24(1): 81 - 91. [Abstract] [Full Text] [PDF]